Literature DB >> 9257694

Effects of melatonin in isolated rat papillary muscle.

P Abete1, S Bianco, C Calabrese, C Napoli, F Cacciatore, N Ferrara, F Rengo.   

Abstract

Melatonin (N-acetyl-5-methoxytryptamine), the principal hormone of the vertebral pineal gland, elicits several neurobiological effects. However, the effects of melatonin on cardiac muscle are still unknown. The first goal of the study was to investigate the role of melatonin on myocardial contractility in isolated rat papillary muscle using dose-response curves to melatonin, to isoproterenol and calcium either in the presence or in the absence of melatonin (0.3 nM). Response curves to isoproterenol were additionally performed in the presence of melatonin plus the specific receptor antagonist N-acetyltryptamine (10 microM); the adenylate-cyclase stimulator forskolin (10 microM) was also used. Melatonin has no direct inotropic effect in isolated rat papillary muscle but counteracts isoproterenol but not [Ca2+] effects. In fact, the EC50 for isoproterenol was significantly higher in the presence than in the absence of melatonin (p < 0.001). This anti-adrenergic action occurs through an interaction to a specific cardiac receptor. Forskolin-stimulated adenylate cyclase induced an increase of contractile force (+118 +/- 25%) which was reduced in the presence of melatonin (+26 +/- 10%; p < 0.01). In conclusion, we found that melatonin possess anti-adrenergic effect in isolated rat papillary muscle. This phenomenon was abolished in the presence of its receptor antagonist N-acetyl-tryptamine demonstrating that melatonin operates through a specific cardiac receptor. The reduction of contractility increase, induced by forskolin-stimulated adenylate cyclase, shows that melatonin may act through a reduction of cyclic AMP accumulation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9257694     DOI: 10.1016/s0014-5793(97)00749-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  7 in total

1.  Acute effects of oral melatonin administration on arterial distensibility, as determined by carotid-femoral pulse wave velocity, in healthy young men.

Authors:  Mustafa Yildiz; Banu Sahin; Alparslan Sahin
Journal:  Exp Clin Cardiol       Date:  2006

Review 2.  Symptom burden in heart failure: assessment, impact on outcomes, and management.

Authors:  Craig M Alpert; Michael A Smith; Scott L Hummel; Ellen K Hummel
Journal:  Heart Fail Rev       Date:  2017-01       Impact factor: 4.214

3.  Protective effect of melatonin against myocardial injury induced by epinephrine.

Authors:  Rastislav Vazan; Tatiana Ravingerova
Journal:  J Physiol Biochem       Date:  2015-01-09       Impact factor: 4.158

4.  Melatonin attenuates alpha-adrenergic-induced contractions by increasing the release of vasoactive intestinal peptide in isolated rat penile bulb.

Authors:  Ercument Olmez; Zehra Kurcer
Journal:  Urol Res       Date:  2003-07-03

Review 5.  Treatment for chronic heart failure in the elderly: current practice and problems.

Authors:  Pasquale Abete; Gianluca Testa; David Della-Morte; Gaetano Gargiulo; Gianluigi Galizia; Domenico de Santis; Antonio Magliocca; Claudia Basile; Francesco Cacciatore
Journal:  Heart Fail Rev       Date:  2013-07       Impact factor: 4.214

Review 6.  Oxidative stress, aging, and diseases.

Authors:  Ilaria Liguori; Gennaro Russo; Francesco Curcio; Giulia Bulli; Luisa Aran; David Della-Morte; Gaetano Gargiulo; Gianluca Testa; Francesco Cacciatore; Domenico Bonaduce; Pasquale Abete
Journal:  Clin Interv Aging       Date:  2018-04-26       Impact factor: 4.458

Review 7.  Exploring New Kingdoms: The Role of Extracellular Vesicles in Oxi-Inflamm-Aging Related to Cardiorenal Syndrome.

Authors:  Cristina Mas-Bargues; Matilde Alique; María Teresa Barrús-Ortiz; Consuelo Borrás; Raquel Rodrigues-Díez
Journal:  Antioxidants (Basel)       Date:  2021-12-29
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.